1 2 3 4 5 6 7 8 9
÷èòàòü äàëåå ... 9; 6; 23—27. 5. Ôåäåðàëüíîå ðóêîâîäñòâî ïî èñïîëüçîâàíèþ ëåêàðñòâåííûõ ñðåäñòâ (×ó÷àëèí À. Ã., Áåëîóñîâ Þ. Á., ßñíåöîâ Â. Â. — ðåä.). — Âûïóñê VII. — 2006. — Ñ. 438—440. 6. Õàðêåâè÷Ä. À. Ôàðìàêîëîãèÿ (8-å èçä.).—Ì.—2004.— Ñ.506—509, 7. Burke A., Smy+h Á. Ì., FitzGerald G. A. Analgesic-antipyretic agents; Pharmacology of gout, In: Goodman&Gilrnan The pharmacological basis of therapeutics (Brunton L. L„ Lazo J. S,. Parker K. L. — eds.). — 2005 (11th edition). — P. 717—736. 8. Choi H. K., Atkinson K., Karlson E. W., Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men // N. Engl. J, Med. — 2004. — Vol. 350. — P. 1093—1103. 9. Choi H. K., A+kinson K,, Karlson E. W. et al. Alcohol intake and risk of incident gout in men: a prospective study // Lancet. — 2004, — Vol. 363.—P. 277—281. 10. Choi H. K„ Mount D. B„ Reginato A. Ì. Pathogenesis of gout //'Ann, Intern, Med. 2005. — Vol. 143. — P. 499—513. 11. Enomoto A., Kimura H.. Chairoungdua A. et al. Molecular identification of î renal urate anion exchanger that regulates blood urate levels // Nature. — 2002. — Vol. 417. — P. 447—452. 12. Hediger Ì. A., Johnson R. J., Miyazaki H., Endou H. Molecular physiology of urate transport // Physiology — 2005. — Vol. 20, — . P. 125—133. 13. McCarthy G, New drugs for crystal deposition diseases // Curr. Opin. Rheumatol.—2006.—Vol.18.—P,170. 14. Moreland L.W. Febuxotat — treatment for hyperuncemia and gout? // N. Engl. J. Med. — 2005. — Vol. 353. — P. 2505—2507. 15. Mount D. B. Molecular physiology and the four-component model of renal urate transport//Curr. Opin. Nephrol. Hypert.—2005.— Vol. 14. — P. 460—463. 16. Oparil S., Zoman Ì. A.. Calhoun D. A. Pathogenesis of hypertension //Ann. Intern. Med. — 2003.— Vol. 139. — P. 761—776. 17. Pacher P., Nivorozhkin A,. Szabo C. Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol//Pharmacol,Rev.—2006.—Vol.58.—P.87—114. 18. Sanchez—Lozada L. G., Nakagawa Ò., Kang D.-H., Feig D. 1. Hormonal and cy+okine effects of uric acid // Curr. Opin. Nephrol, Hypert. — 2006. — Vol. 15. — P. 30—33. 19. Terkeltaub R. A. Gout. // N. Engl. J. Med. — 2005. —Vol. 349. — P. 1647—1655. 20. Willett W. C., Stampfer Ì. J. Rebuilding the food pyramid // Scl. Am,— 2003.— Vol.288.— P. 64— 71. 21. Wortmonn R. L. Recent advances in the management of gout and hyperuricemia// Curr. Opin. Rheumatol. —2005. —Vol. 17, — P. 319— 324.Èñòî÷íèê: Ôèñåíêî Â. Âðà÷. 2006. ¹14. Ñ.3-7